Peter M. Kanter

1.7k total citations
48 papers, 1.4k citations indexed

About

Peter M. Kanter is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter M. Kanter has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter M. Kanter's work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Peter M. Kanter is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (5 papers) and Nanoparticle-Based Drug Delivery (5 papers). Peter M. Kanter collaborates with scholars based in United States, Canada and Switzerland. Peter M. Kanter's co-authors include Herbert S. Schwartz, Charles E. Wenner, Licia Tomei, Carl W. Porter, Juhani Jänne, Maria Halmekytö, Marko Pietilä, Leena Alhonen, Constantine P. Karakousis and Frank G. Pilkiewicz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Peter M. Kanter

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter M. Kanter United States 21 620 417 195 164 123 48 1.4k
Asterios S. Tsiftsoglou Greece 25 1.3k 2.0× 334 0.8× 83 0.4× 172 1.0× 157 1.3× 93 2.5k
M. Baccarani-Contri Italy 18 808 1.3× 141 0.3× 105 0.5× 128 0.8× 106 0.9× 20 1.8k
Naofumi Yamauchi Japan 23 925 1.5× 280 0.7× 127 0.7× 193 1.2× 120 1.0× 63 1.7k
Jordi Pétriz Spain 23 695 1.1× 307 0.7× 130 0.7× 207 1.3× 91 0.7× 85 1.7k
Weiwei Yu China 24 937 1.5× 338 0.8× 130 0.7× 315 1.9× 77 0.6× 49 1.8k
David A. Slatter United Kingdom 20 711 1.1× 138 0.3× 90 0.5× 203 1.2× 96 0.8× 31 1.7k
Wonhee Hur South Korea 26 997 1.6× 356 0.9× 109 0.6× 434 2.6× 132 1.1× 60 1.9k
Jie Gao China 24 910 1.5× 251 0.6× 128 0.7× 296 1.8× 235 1.9× 90 1.7k
Chunlei Zhang China 27 1.7k 2.7× 464 1.1× 120 0.6× 293 1.8× 61 0.5× 89 3.2k
Qi Xie China 22 519 0.8× 403 1.0× 150 0.8× 278 1.7× 147 1.2× 87 1.6k

Countries citing papers authored by Peter M. Kanter

Since Specialization
Citations

This map shows the geographic impact of Peter M. Kanter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Kanter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Kanter more than expected).

Fields of papers citing papers by Peter M. Kanter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Kanter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Kanter. The network helps show where Peter M. Kanter may publish in the future.

Co-authorship network of co-authors of Peter M. Kanter

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Kanter. A scholar is included among the top collaborators of Peter M. Kanter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Kanter. Peter M. Kanter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bertone, Alicia L., et al.. (2014). Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses. American Journal of Veterinary Research. 75(2). 141–151. 74 indexed citations
2.
Nair, Bindu M., Wojciech G. Lesniak, Wei Tan, et al.. (2012). In vivo toxicity evaluation of gold-dendrimer composite nanodevices with different surface charges. Nanotoxicology. 7(4). 441–451. 11 indexed citations
3.
Song, Liguo, Joshua Prey, Jun Xue, et al.. (2005). Pharmacokinetic measurements of IDN 5390 using electrospray ionization tandem mass spectrometry: structure characterization and quantification in dog plasma. Rapid Communications in Mass Spectrometry. 19(24). 3617–3625. 9 indexed citations
4.
Woodie, J. Brett, Norm G. Ducharme, Peter M. Kanter, Richard P. Hackett, & Hollis N. Erb. (2005). Surgical advancement of the larynx (laryngeal tie‐forward) as a treatment for dorsal displacement of the soft palate in horses: a prospective study 2001–2004. Equine Veterinary Journal. 37(5). 418–423. 51 indexed citations
5.
Ramnath, Nithya, Gary N. Schwartz, Scott N. Holden, et al.. (2004). A Phase I and Pharmacokinetic Study of BAY59: A Novel Taxane. Oncology. 67(2). 123–129. 6 indexed citations
6.
Thomas, Sufi M., Qing Zeng, Kevin F. Dyer, et al.. (2003). Tissue distribution of liposome-mediated epidermal growth factor receptor antisense gene therapy. Cancer Gene Therapy. 10(7). 518–528. 13 indexed citations
7.
Zeng, Qing, Peter M. Kanter, Rajiv Dhir, et al.. (2002). Lack of toxicity of EGFR antisense gene therapy. PubMed. 2(3). 174–186. 12 indexed citations
8.
Gupta, Atul, Ronald Alberico, Alan Litwin, Peter M. Kanter, & Z GROSSMAN. (2002). Gadopentetate Dimeglumine Is Potentially an Alternative Contrast Agent for Three-Dimensional Computed Tomography Angiography with Multidetector-Row Helical Scanning. Journal of Computer Assisted Tomography. 26(6). 869–874. 15 indexed citations
9.
Ojima, Iwao, Jean Veith, Paula Pera, et al.. (2001). Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance. JNCI Journal of the National Cancer Institute. 93(16). 1234–1245. 74 indexed citations
10.
Webb, Murray S., Peter M. Kanter, Karen A. Gelmon, et al.. (1998). Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer. Cancer Chemotherapy and Pharmacology. 42(6). 461–470. 54 indexed citations
11.
Pietilä, Marko, Leena Alhonen, Maria Halmekytö, et al.. (1997). Activation of Polyamine Catabolism Profoundly Alters Tissue Polyamine Pools and Affects Hair Growth and Female Fertility in Transgenic Mice Overexpressing Spermidine/SpermineN 1-Acetyltransferase. Journal of Biological Chemistry. 272(30). 18746–18751. 112 indexed citations
12.
Kanter, Peter M., et al.. (1994). Induction of dog IL-1 by free and liposomal encapsulated doxorubicin. Anti-Cancer Drugs. 5(3). 355–360. 2 indexed citations
13.
14.
Kanter, Peter M., et al.. (1994). Preclinical toxicologic evaluation of DENSPM (N1, N11-diethylnorspermine) in rats and dogs. Anti-Cancer Drugs. 5(4). 448–456. 4 indexed citations
15.
Schieweck, Klaus, et al.. (1989). CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties. Cancer Chemotherapy and Pharmacology. 23(6). 341–347. 3 indexed citations
16.
Tomei, Licia, Peter M. Kanter, & Charles E. Wenner. (1988). Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochemical and Biophysical Research Communications. 155(1). 324–331. 122 indexed citations
17.
Kanter, Peter M., Herbert S. Schwartz, & Charles R. West. (1983). Functional and Chemical Markers of PCNU Activity. PubMed. 1(1). 11–20. 5 indexed citations
18.
Kanter, Peter M. & Herbert S. Schwartz. (1980). Post-repair DNA Damage in X-irradiated Cultured Human Tumour Cells. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 38(5). 483–493. 11 indexed citations
19.
Kanter, Peter M. & Herbert S. Schwartz. (1979). Effects of N-trifluoroacetyladriamycin-14-valerate and related agents on DNA strand damage and thymidine incorporation in CCRF-CEM cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39(2 Pt 1). 448–51. 18 indexed citations
20.
Schwartz, Herbert S. & Peter M. Kanter. (1979). Chemical interactions of cardiolipin with daunorubicin and other intercalating agents. European Journal of Cancer (1965). 15(6). 923–928. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asterios S. Tsiftsoglou Breakdown of academic impact, for papers by M. Baccarani-Contri Breakdown of academic impact, for papers by Naofumi Yamauchi Breakdown of academic impact, for papers by Jordi Pétriz Breakdown of academic impact, for papers by Weiwei Yu Breakdown of academic impact, for papers by David A. Slatter Breakdown of academic impact, for papers by Wonhee Hur Breakdown of academic impact, for papers by Jie Gao Breakdown of academic impact, for papers by Chunlei Zhang Breakdown of academic impact, for papers by Qi Xie
Rankless by CCL
2026